The FDA is announcing the opening of a public docket to receive information and comments on laser-assisted in situ keratomileusis (LASIK).
Federal Register: Medical Devices: Ophthalmic Devices; Laser-Assisted In Situ Keratomileusis (LASIK) Devices; Establishing a Docket
Rituxan Linked to Fatal PML Case
Clinicians advised to consider PML in rituximab-treated patients presenting with new-onset neurologic manifestations.
Medscape Medical News
Methadone Dosages Correlate Poorly with Serum Levels
A new study shows a poor correlation between dosages of methadone given to chronic pain patients and resulting serum levels. The findings, researchers say, complicate any cause-and-effect conclusions in the rising number of deaths associated with methadone use.
Medscape Medical News
FDA Safety Changes: Viramune, Agrylin, Keflex, Furadantin, Mycobutin
The FDA has approved revisions to the safety labeling for nevirapine tablets and oral solution, anagrelide HCl capsules, cephalexin capsules, nitrofurantoin oral suspension, and rifabutin capsules.
Medscape Medical News
Ten Years Later, UKPDS Shows Intensive Glucose Lowering, but Not Tight BP Control, Reduces MI, All-Cause Mortality
Monitoring from a landmark study indicates that intensive glucose lowering has significant effects on major diabetes endpoints and on the risks for myocardial infarction and all-cause mortality.
Medscape Medical News
Pain May Be a Nonmotor Feature of Parkinson’s Disease
Results of case-control study suggest that pain begins at the clinical onset of Parkinson’s disease and support the hypothesis that pain should be considered a nonmotor feature of the disease.
Medscape Medical News
Alpharma Urges Shareholders to Take No Action with Respect to King Pharmaceuticals’ Announced Intent to Commence a Tender Offer
BRIDGEWATER, N.J.–(BUSINESS WIRE)–Sep 11, 2008 - The Board of Directors of Alpharma Inc. (NYSE: ALO), a global specialty pharmaceutical company, today urged shareholders to take no action with respect to the announcement by King Pharmaceuticals,…
FDA MedWatch- Rituxan (rituximab)- Important New Safety Information Regarding Progressive Multifocal Leukoencephalopathy With The Use Of Rituxan
ROCKVILLE, Md., Sept. 11, 2008–Genentech informed healthcare professionals of revisions to prescribing information for Rituxan regarding a case of progressive multifocal leukoencephalopathy (PML) leading to death in a patient with rheumatoid…
Trubion Pharmaceuticals Wins Patent Opposition - Genentech / Biogen Idec European Patent Revoked
SEATTLE, September 11, 2008 /PRNewswire-FirstCall/ — Trubion Pharmaceuticals, Inc. , today announced that the Opposition Division (OD) of the European Patent Office (EPO) has revoked Genentech and Biogen Idec’s European Patent 1176981, in its…
FDA: West Virginia Livestock Owner Sentenced in Criminal and Civil Contempt Case
The U.S. Food and Drug Administration announced today that a West Virginia cattle dealer has been sentenced to six months probation for refusing to obey court orders in 2006 and 2008 that prohibited her from introducing animals into the food supply until the FDA had approved her record-keeping system. The FDA initiated the case after illegal levels of drug residue were found repeatedly in calves that Shirley A. Rhodes of Sandyville sold for use as human food.
Social Network
| M | T | W | T | F | S | S |
|---|---|---|---|---|---|---|
| « Aug | Oct » | |||||
| 1 | 2 | 3 | 4 | 5 | 6 | 7 |
| 8 | 9 | 10 | 11 | 12 | 13 | 14 |
| 15 | 16 | 17 | 18 | 19 | 20 | 21 |
| 22 | 23 | 24 | 25 | 26 | 27 | 28 |
| 29 | 30 | |||||
Recent Entries
- Consumer Directed Questions and Answers about FDA’s Initiative Against Contaminated Weight Loss Products
- Guidance for Industry
- QuantRx(R) Announces FDA 510(k) Clearance For Its RapidSense(R) Methamphetamine Test
- New Test Will Catch Sports Cheats On New Endurance Drugs
- BASi Receives A European Patent For Culex(R)
- Binge Drinking Among MSM In New York City Linked To Increased HIV Risk, Study Says
- Wegmans Food Markets To Offer No-Cost Generic Antibiotics Through March
- CMS Finalizes Medicare Rule That Aims To Stop Pharmacy Benefit Manager Practice That Inflates Drug Costs For Some Beneficiaries
- ExCell Study Joined By Children’s Memorial Hospital, Chicago
- Participants To Interact Online With US FDA In Process Validation Webinar
Recent Comments
- Keine Kommentare vorhanden.
Translators
Categories
- Addictions
- Alcohol Abuse
- Complementary and Alternative Medicine
- Drug Approvals
- Drug Evaluation and Research
- Drug Shortages
- Drugs and Food Information
- Food and Nutrition Information
- Health Information
- Illegal Drugs
- Medical Devices
- Medical Devices and Radiological Health
- Pharmaceutical Industry News
- Pharmacist News
- Safety Information
- Uncategorized
Archives
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
- August 2007
- July 2007
- June 2007
- May 2007
- April 2007
- March 2007
- February 2007
- January 2007
- December 2006
- November 2006
- October 2006
- September 2006
- August 2006
- July 2006
- June 2006
- May 2006
- April 2006
- March 2006
- February 2006
- January 2006
- December 1969
Pages
Blogroll
- Alcohol / Addiction / Illegal Drugs News From Medical News Today - Latest Alcohol / Addiction / Illegal Drugs News From Medical News Today.
- Alcohol and Alcoholism - current issue - Alcohol and Alcoholism - RSS feed of current issue
- CDRH Consumer News - Items added to the Center for Devices and Radiological Health’s Consumer website within the last month.
- Centre for Reviews and Dissemination (CRD) - CRD undertakes reviews of research about the effects of interventions used in health and social care.
- Complementary and Altern